Suppr超能文献

[慢性活动性病毒性肝炎的干扰素治疗]

[Interferon therapy in chronic active viral hepatitis].

作者信息

Lengyel G, Fehér J

机构信息

II. Belklinika, Semmelweis Orvostudományi Egyetem, Budapest.

出版信息

Orv Hetil. 1995 Jan 1;136(1):3-7.

PMID:7531317
Abstract

The authors give a short review of the recent data about the types of interferons and their biological activity. The role of interferons in the therapy of B, C and D chronic viral hepatitis is discussed. Interferon treatment means a substantial progress in the therapy of chronic viral hepatitis, however it represents a final recovery from chronic B or C hepatitis only in 25-40 percent or 40-45 percent of the cases, respectively. The authors refer to the combination therapy which seems to be promising in the future.

摘要

作者对近期有关干扰素类型及其生物活性的数据进行了简要综述。讨论了干扰素在治疗B型、C型和D型慢性病毒性肝炎中的作用。干扰素治疗意味着慢性病毒性肝炎治疗取得了重大进展,然而,它仅分别使25% - 40%或40% - 45%的慢性B型或C型肝炎病例最终康复。作者提到了联合治疗,这在未来似乎很有前景。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验